MedicationUse-v1.0.1(2015EN): verschil tussen versies
(Nieuwe pagina aangemaakt met '==General information== Name: '''nl.nfu.MedicationUse''' link=MedicatieGebruik-v1.0.1(2015NL)<BR> Version: '''1.0.1''' <br> HCIM Status:Final<...') |
|||
Regel 3: | Regel 3: | ||
Version: '''1.0.1''' <br> | Version: '''1.0.1''' <br> | ||
HCIM Status:Final<br> | HCIM Status:Final<br> | ||
− | + | Release: '''2015''' <br> | |
Release status: Published<br> | Release status: Published<br> | ||
− | + | Release date: 1-4-2015 | |
----- | ----- | ||
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2015(EN)]] [[HCIM_Release_2015(EN) |Back to HCIM list ]]</div> | <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2015(EN)]] [[HCIM_Release_2015(EN) |Back to HCIM list ]]</div> | ||
Regel 119: | Regel 119: | ||
==Information Model== | ==Information Model== | ||
<BR> | <BR> | ||
− | + | <imagemap> Bestand:MedicationUse-v1.0.1Model(EN).png | center | |
+ | rect 679 205 847 274 [[MedicationPrescription-v1.0.1(2015EN)]] | ||
+ | rect 251 46 424 116 [[MedicationPrescription-v1.0.1(2015EN)]] | ||
+ | rect 423 205 545 275 [[#11150]] | ||
+ | rect 70 497 332 547 [[#MedicationUseReasonForInterruptionCodelist]] | ||
+ | rect 97 407 306 477 [[#11158]] | ||
+ | rect 359 497 601 547 [[#MedicationUseReasonForDiscontinuationCodelist]] | ||
+ | rect 388 407 573 477 [[#11159]] | ||
+ | rect 650 497 831 547 [[#MedicationUseStatusCodelist]] | ||
+ | rect 540 46 732 116 [[MedicationPrescription-v1.0.1(2015EN)]] | ||
+ | rect 679 407 801 477 [[#11154]] | ||
+ | rect 149 205 271 275 [[#11863]] | ||
+ | desc none | ||
+ | </imagemap> | ||
<BR> | <BR> | ||
{| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px" | {| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px" | ||
Regel 125: | Regel 138: | ||
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference | |style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference | ||
|-style="vertical-align:top; background-color: #E3E3E3; " | |-style="vertical-align:top; background-color: #E3E3E3; " | ||
− | |style = "text-align:center" |[[Bestand: block.png| 20px]] | + | |style = "text-align:center" |[[Bestand: block.png| 20px | link=]] |
||NL-CM:9.2.1 | ||NL-CM:9.2.1 | ||
− | |colspan ="6" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruik">[[Bestand: arrowdown.png | 10px]]MedicationUse</span> | + | |colspan ="6" style ="padding-left: 0px"|<span Id=11150 Title="NL: MedicatieGebruik">[[Bestand: arrowdown.png | 10px | link=]]MedicationUse</span> |
| | | | ||
|Root concept of the MedicationUse building block. This root concept contains all data elements of the MedicationUse building block. | |Root concept of the MedicationUse building block. This root concept contains all data elements of the MedicationUse building block. | ||
Regel 133: | Regel 146: | ||
| | | | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
− | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]] | + | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]] |
||NL-CM:9.2.2 | ||NL-CM:9.2.2 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
− | |colspan ="5" style ="padding-left: 0px"|<span Title="NL: GebruiksProduct::Product">[[Bestand: arrowright.png | 10px]]ProductUsed::Product</span> | + | |colspan ="5" style ="padding-left: 0px"|<span Id=11151 Title="NL: GebruiksProduct::Product">[[Bestand: arrowright.png | 10px | link=]]ProductUsed::Product</span> |
|1 | |1 | ||
|The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well. | |The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well. | ||
Regel 146: | Regel 159: | ||
{| | {| | ||
|- | |- | ||
− | |[[Bestand: block.png]]||[[MedicationPrescription-v1.0.1(2015EN) |MedicationPrescription]] | + | |[[Bestand: block.png | link=MedicationPrescription-v1.0.1(2015EN)]]||[[MedicationPrescription-v1.0.1(2015EN) |MedicationPrescription]] |
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
− | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]] | + | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]] |
||NL-CM:9.2.3 | ||NL-CM:9.2.3 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
− | |colspan ="5" style ="padding-left: 0px"|<span Title="NL: Voorschrift::MedicatieVoorschrift">[[Bestand: arrowright.png | 10px]]Prescription</span> | + | |colspan ="5" style ="padding-left: 0px"|<span Id=11155 Title="NL: Voorschrift::MedicatieVoorschrift">[[Bestand: arrowright.png | 10px | link=]]Prescription</span> |
|0..* | |0..* | ||
|The agreement or order for the use of medication. | |The agreement or order for the use of medication. | ||
Regel 159: | Regel 172: | ||
{| | {| | ||
|- | |- | ||
− | |[[Bestand: block.png]]||[[MedicationPrescription-v1.0.1(2015EN) |MedicationPrescription]] | + | |[[Bestand: block.png | link=MedicationPrescription-v1.0.1(2015EN)]]||[[MedicationPrescription-v1.0.1(2015EN) |MedicationPrescription]] |
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
− | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]] | + | |style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]] |
||NL-CM:9.2.4 | ||NL-CM:9.2.4 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
− | |colspan ="5" style ="padding-left: 0px"|<span Title="NL: GebruiksDosering::Dosering">[[Bestand: arrowright.png | 10px]]UsedDosage::Dosage</span> | + | |colspan ="5" style ="padding-left: 0px"|<span Id=11153 Title="NL: GebruiksDosering::Dosering">[[Bestand: arrowright.png | 10px | link=]]UsedDosage::Dosage</span> |
|0..* | |0..* | ||
|When taking stock of medication use, the dosage describes the amount and the pattern of use as reported by the patient or a healthcare provider. | |When taking stock of medication use, the dosage describes the amount and the pattern of use as reported by the patient or a healthcare provider. | ||
Regel 175: | Regel 188: | ||
{| | {| | ||
|- | |- | ||
− | |[[Bestand: block.png]]||[[MedicationPrescription-v1.0.1(2015EN) |MedicationPrescription]] | + | |[[Bestand: block.png | link=MedicationPrescription-v1.0.1(2015EN)]]||[[MedicationPrescription-v1.0.1(2015EN) |MedicationPrescription]] |
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
− | |style = "text-align:center" |[[Bestand: CD.png| 16px]] | + | |style = "text-align:center" |[[Bestand: CD.png| 16px | link=]] |
||NL-CM:9.2.5 | ||NL-CM:9.2.5 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
− | |colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikStatus">[[Bestand: arrowright.png | 10px]]MedicationUseStatus</span> | + | |colspan ="5" style ="padding-left: 0px"|<span Id=11154 Title="NL: MedicatieGebruikStatus">[[Bestand: arrowright.png | 10px | link=]]MedicationUseStatus</span> |
|1 | |1 | ||
|The status or status code is important in indicating the use schedule. | |The status or status code is important in indicating the use schedule. | ||
Regel 199: | Regel 212: | ||
{| | {| | ||
|- | |- | ||
− | |[[Bestand: List2.png]]||[[#MedicationUseStatusCodelist|MedicationUseStatusCodelist]] | + | |[[Bestand: List2.png | link=#MedicationUseStatusCodelist]]||[[#MedicationUseStatusCodelist|MedicationUseStatusCodelist]] |
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
− | |style = "text-align:center" |[[Bestand: CD.png| 16px]] | + | |style = "text-align:center" |[[Bestand: CD.png| 16px | link=]] |
||NL-CM:9.2.6 | ||NL-CM:9.2.6 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
− | |colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikRedenVanStoppen">[[Bestand: arrowright.png | 10px]]MedicationUseReasonForDiscontinuation</span> | + | |colspan ="5" style ="padding-left: 0px"|<span Id=11159 Title="NL: MedicatieGebruikRedenVanStoppen">[[Bestand: arrowright.png | 10px | link=]]MedicationUseReasonForDiscontinuation</span> |
|0..1 | |0..1 | ||
|Reason why the use of a certain medicine was discontinued. | |Reason why the use of a certain medicine was discontinued. | ||
Regel 212: | Regel 225: | ||
{| | {| | ||
|- | |- | ||
− | |[[Bestand: List2.png]]||[[#MedicationUseReasonForDiscontinuationCodelist|MedicationUseReasonForDiscontinuationCodelist]] | + | |[[Bestand: List2.png | link=#MedicationUseReasonForDiscontinuationCodelist]]||[[#MedicationUseReasonForDiscontinuationCodelist|MedicationUseReasonForDiscontinuationCodelist]] |
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
− | |style = "text-align:center" |[[Bestand: CD.png| 16px]] | + | |style = "text-align:center" |[[Bestand: CD.png| 16px | link=]] |
||NL-CM:9.2.7 | ||NL-CM:9.2.7 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
− | |colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikRedenVanOnderbreken">[[Bestand: arrowright.png | 10px]]MedicationUseReasonForInterruption</span> | + | |colspan ="5" style ="padding-left: 0px"|<span Id=11158 Title="NL: MedicatieGebruikRedenVanOnderbreken">[[Bestand: arrowright.png | 10px | link=]]MedicationUseReasonForInterruption</span> |
|0..1 | |0..1 | ||
|Reason why the use of a certain medicine was interrupted. Here, you can choose to enter text or one of the codes. | |Reason why the use of a certain medicine was interrupted. Here, you can choose to enter text or one of the codes. | ||
Regel 225: | Regel 238: | ||
{| | {| | ||
|- | |- | ||
− | |[[Bestand: List2.png]]||[[#MedicationUseReasonForInterruptionCodelist|MedicationUseReasonForInterruptionCodelist]] | + | |[[Bestand: List2.png | link=#MedicationUseReasonForInterruptionCodelist]]||[[#MedicationUseReasonForInterruptionCodelist|MedicationUseReasonForInterruptionCodelist]] |
|} | |} | ||
|-style="vertical-align:top; background-color: transparent; " | |-style="vertical-align:top; background-color: transparent; " | ||
− | |style = "text-align:center" |[[Bestand: ST.png| 16px]] | + | |style = "text-align:center" |[[Bestand: ST.png| 16px | link=]] |
||NL-CM:9.2.8 | ||NL-CM:9.2.8 | ||
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | |style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" | | ||
− | |colspan ="5" style ="padding-left: 0px"|<span Title="NL: Toelichting">[[Bestand: arrowright.png | 10px]]Explanation</span> | + | |colspan ="5" style ="padding-left: 0px"|<span Id=11863 Title="NL: Toelichting">[[Bestand: arrowright.png | 10px | link=]]Explanation</span> |
|0..1 | |0..1 | ||
|Comments on the medication use. | |Comments on the medication use. | ||
Regel 245: | Regel 258: | ||
{|class="wikitable" width="975px" style= "font-size: 9.5pt;" | {|class="wikitable" width="975px" style= "font-size: 9.5pt;" | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
− | | style="background-color: #1F497D; width: 15%; color | + | | style="background-color: #1F497D; width: 15%; "|<font color=#FFFFFF><b>GebruiksProduct</b></font> |
− | |colspan="4" style="background-color: #1F497D; width: 51%; color | + | |colspan="4" style="background-color: #1F497D; width: 51%; "|<font color=#FFFFFF><b>GebruiksDosering</b></font> |
− | | style="background-color: #1F497D; width: 21%; color | + | | style="background-color: #1F497D; width: 21%; "|<font color=#FFFFFF><b>MedicatieGebruikStatus</b></font> |
− | | style="background-color: #1F497D; width: 13%; color | + | | style="background-color: #1F497D; width: 13%; "|<font color=#FFFFFF><b>Voorschrift</b></font> |
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
− | | style="background-color: #548DD4; width: 15%; color | + | | style="background-color: #548DD4; width: 15%; "|<font color=#FFFFFF><b>ProductNaam</b></font> |
− | | style="background-color: #548DD4; width: 12%; color | + | | style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>StartDatum</b></font> |
− | | style="background-color: #548DD4; width: 10%; color | + | | style="background-color: #548DD4; width: 10%; "|<font color=#FFFFFF><b>EindDatum</b></font> |
− | | style="background-color: #548DD4; width: 17%; color | + | | style="background-color: #548DD4; width: 17%; "|<font color=#FFFFFF><b>Keerdosis <noWiki>|</noWiki> Toedieningsschema</b></font> |
− | | style="background-color: #548DD4; width: 12%; color | + | | style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>ToedieningsWeg</b></font> |
| style="background-color: #548DD4; width: 21%; "| | | style="background-color: #548DD4; width: 21%; "| | ||
− | | style="background-color: #548DD4; width: 13%; color | + | | style="background-color: #548DD4; width: 13%; "|<font color=#FFFFFF><b>Reden van Voorschrijven</b></font> |
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="background-color: #D9D9D9; width: 15%; "| | | style="background-color: #D9D9D9; width: 15%; "| | ||
Regel 264: | Regel 277: | ||
| style="background-color: #D9D9D9; width: 12%; "| | | style="background-color: #D9D9D9; width: 12%; "| | ||
| style="background-color: #D9D9D9; width: 21%; "| | | style="background-color: #D9D9D9; width: 21%; "| | ||
− | | style="background-color: #D9D9D9; width: 13% | + | | style="background-color: #D9D9D9; width: 13%; "|<b>Probleem</b> |
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 15%; "|Paracetamol tablet 500 mg | | style="width: 15%; "|Paracetamol tablet 500 mg | ||
Regel 276: | Regel 289: | ||
{|class="wikitable" width="975px" style= "font-size: 9.5pt;" | {|class="wikitable" width="975px" style= "font-size: 9.5pt;" | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
− | | style="background-color: #1F497D; width: 15%; color | + | | style="background-color: #1F497D; width: 15%; "|<font color=#FFFFFF><b>GebruiksProduct</b></font> |
− | |colspan="4" style="background-color: #1F497D; width: 51%; color | + | |colspan="4" style="background-color: #1F497D; width: 51%; "|<font color=#FFFFFF><b>GebruiksDosering</b></font> |
− | | style="background-color: #1F497D; width: 21%; color | + | | style="background-color: #1F497D; width: 21%; "|<font color=#FFFFFF><b>MedicatieGebruikStatus</b></font> |
− | | style="background-color: #1F497D; width: 13%; color | + | | style="background-color: #1F497D; width: 13%; "|<font color=#FFFFFF><b>Voorschrift</b></font> |
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
− | | style="background-color: #548DD4; width: 15%; color | + | | style="background-color: #548DD4; width: 15%; "|<font color=#FFFFFF><b>ProductNaam</b></font> |
− | | style="background-color: #548DD4; width: 12%; color | + | | style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>StartDatum</b></font> |
− | | style="background-color: #548DD4; width: 10%; color | + | | style="background-color: #548DD4; width: 10%; "|<font color=#FFFFFF><b>EindDatum</b></font> |
− | | style="background-color: #548DD4; width: 17%; color | + | | style="background-color: #548DD4; width: 17%; "|<font color=#FFFFFF><b>Keerdosis <noWiki>|</noWiki> Toedieningsschema</b></font> |
− | | style="background-color: #548DD4; width: 12%; color | + | | style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>ToedieningsWeg</b></font> |
| style="background-color: #548DD4; width: 21%; "| | | style="background-color: #548DD4; width: 21%; "| | ||
− | | style="background-color: #548DD4; width: 13%; color | + | | style="background-color: #548DD4; width: 13%; "|<font color=#FFFFFF><b>Reden van Voorschrijven</b></font> |
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="background-color: #D9D9D9; width: 15%; "| | | style="background-color: #D9D9D9; width: 15%; "| | ||
Regel 295: | Regel 308: | ||
| style="background-color: #D9D9D9; width: 12%; "| | | style="background-color: #D9D9D9; width: 12%; "| | ||
| style="background-color: #D9D9D9; width: 21%; "| | | style="background-color: #D9D9D9; width: 21%; "| | ||
− | | style="background-color: #D9D9D9; width: 13% | + | | style="background-color: #D9D9D9; width: 13%; "|<b>Probleem</b> |
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 15%; "|Pantoprazol injpdr 40mg fl | | style="width: 15%; "|Pantoprazol injpdr 40mg fl | ||
Regel 307: | Regel 320: | ||
{|class="wikitable" width="975px" style= "font-size: 9.5pt;" | {|class="wikitable" width="975px" style= "font-size: 9.5pt;" | ||
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
− | | style="background-color: #1F497D; width: 15%; color | + | | style="background-color: #1F497D; width: 15%; "|<font color=#FFFFFF><b>GebruiksProduct</b></font> |
− | |colspan="4" style="background-color: #1F497D; width: 51%; color | + | |colspan="4" style="background-color: #1F497D; width: 51%; "|<font color=#FFFFFF><b>GebruiksDosering</b></font> |
− | | style="background-color: #1F497D; width: 21%; color | + | | style="background-color: #1F497D; width: 21%; "|<font color=#FFFFFF><b>MedicatieGebruikStatus</b></font> |
− | | style="background-color: #1F497D; width: 13%; color | + | | style="background-color: #1F497D; width: 13%; "|<font color=#FFFFFF><b>Voorschrift</b></font> |
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
− | | style="background-color: #548DD4; width: 15%; color | + | | style="background-color: #548DD4; width: 15%; "|<font color=#FFFFFF><b>ProductNaam</b></font> |
− | | style="background-color: #548DD4; width: 12%; color | + | | style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>StartDatum</b></font> |
− | | style="background-color: #548DD4; width: 10%; color | + | | style="background-color: #548DD4; width: 10%; "|<font color=#FFFFFF><b>EindDatum</b></font> |
− | | style="background-color: #548DD4; width: 17%; color | + | | style="background-color: #548DD4; width: 17%; "|<font color=#FFFFFF><b>Keerdosis <noWiki>|</noWiki> Toedieningsschema</b></font> |
− | | style="background-color: #548DD4; width: 12%; color | + | | style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>ToedieningsWeg</b></font> |
| style="background-color: #548DD4; width: 21%; "| | | style="background-color: #548DD4; width: 21%; "| | ||
− | | style="background-color: #548DD4; width: 13%; color | + | | style="background-color: #548DD4; width: 13%; "|<font color=#FFFFFF><b>Reden van Voorschrijven</b></font> |
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="background-color: #D9D9D9; width: 15%; "| | | style="background-color: #D9D9D9; width: 15%; "| | ||
Regel 326: | Regel 339: | ||
| style="background-color: #D9D9D9; width: 12%; "| | | style="background-color: #D9D9D9; width: 12%; "| | ||
| style="background-color: #D9D9D9; width: 21%; "| | | style="background-color: #D9D9D9; width: 21%; "| | ||
− | | style="background-color: #D9D9D9; width: 13% | + | | style="background-color: #D9D9D9; width: 13%; "|<b>Probleem</b> |
|-style=vertical-align:top; | |-style=vertical-align:top; | ||
| style="width: 15%; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml | | style="width: 15%; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml | ||
Regel 531: | Regel 544: | ||
+ | ==This information model in other releases== | ||
+ | <ul> | ||
+ | <li>[[MedicationUse-v3.0(2016EN) | Release 2016, (Version 3.0)]]</li> | ||
+ | </ul> | ||
==More on this information model== | ==More on this information model== | ||
− | + | To exchange information based on health and care information models, additional, more technical specifications are required.<BR> | |
+ | Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications: | ||
+ | <ul> | ||
+ | <li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2015bbr-?id=2.16.840.1.113883.2.4.3.11.60.5.4.2.9.2&effectiveDate=2015-04-01T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li> | ||
+ | <li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR [https://simplifier.net/NictizSTU3/~resources?text=zib&category=StructureDefinition [[File:fhir.png|link=]]]</li> | ||
+ | </ul> | ||
This information model is also available as [[Media:nl.nfu.MedicationUse-v1.0.1(2015EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.nfu.MedicationUse-v1.0.1(2015EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]] | This information model is also available as [[Media:nl.nfu.MedicationUse-v1.0.1(2015EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.nfu.MedicationUse-v1.0.1(2015EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]] | ||
==About this information== | ==About this information== | ||
The information in this wikipage is based on ''Registratie aan de bron'' publication 2015 including errata dd. 16-07-2015 <BR> | The information in this wikipage is based on ''Registratie aan de bron'' publication 2015 including errata dd. 16-07-2015 <BR> | ||
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR> | Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR> | ||
− | This page is generated on | + | This page is generated on 24/01/2018 17:12:37 <BR> |
----- | ----- | ||
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2015(EN)]] [[HCIM_Release_2015(EN) |Back to HCIM list ]]</div> | <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2015(EN)]] [[HCIM_Release_2015(EN) |Back to HCIM list ]]</div> |
Versie van 24 jan 2018 om 23:20
Inhoud
General information
Name: nl.nfu.MedicationUse
Version: 1.0.1
HCIM Status:Final
Release: 2015
Release status: Published
Release date: 1-4-2015
Metadata
DCM::CoderList | Kerngroep Registratie aan de Bron |
DCM::ContactInformation.Address | |
DCM::ContactInformation.Name | * |
DCM::ContactInformation.Telecom | |
DCM::ContentAuthorList | Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron |
DCM::CreationDate | 19-12-2013 |
DCM::DeprecatedDate | |
DCM::DescriptionLanguage | nl |
DCM::EndorsingAuthority.Address | |
DCM::EndorsingAuthority.Name | NFU |
DCM::EndorsingAuthority.Telecom | |
DCM::Id | 2.16.840.1.113883.2.4.3.11.60.40.3.9.2 |
DCM::KeywordList | Medicatie, Feitelijk Gebruik, Gebruik |
DCM::LifecycleStatus | Final |
DCM::ModelerList | Kerngroep Registratie aan de Bron |
DCM::Name | nl.nfu.MedicatieGebruik |
DCM::PublicationDate | 1-4-2015 |
DCM::PublicationStatus | Published |
DCM::ReviewerList | Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron |
DCM::RevisionDate | 22-5-2015 |
DCM::Superseeds | nl.nfu.OverdrachtMedicatie-v1.1 (2.16.840.1.113883.2.4.3.11.60.40.3.9.1) |
DCM::Version | 1.0.1 |
HCIM::PublicationLanguage | EN |
Revision History
Only available in Dutch
Publicatieversie 1.0 (01-04-2015)
ZIB-56 | RFC Bouwsteen Medicatie |
ZIB-308 | Prefix Overdracht weggehaald bij de generieke bouwstenen |
Incl. algemene wijzigingsverzoeken:
ZIB-94 | Aanpassen tekst van Disclaimer, Terms of Use & Copyrights |
ZIB-154 | Consequenties opsplitsing Medicatie bouwstenen voor overige bouwstenen. |
ZIB-200 | Naamgeving SNOMED CT in tagged values klinische bouwstenen gelijk getrokken. |
ZIB-201 | Naamgeving OID: in tagged value notes van klinische bouwstenen gelijk getrokken. |
ZIB-309 | EOI aangepast |
ZIB-324 | Codelijsten Name en Description beginnen met een Hoofdletter |
ZIB-326 | Tekstuele aanpassingen conform de kwaliteitsreview kerngroep 2015 |
Publicatieversie 1.0.1 (22-05-2015)
ZIB-381 | Onterecht een spatie achter "OID :" in tagged value notes van tagged value DCM::ValueSet MedicatieGebruikRedenVanStoppenCodelijst van concept MedicatieGebruikRedenVanStoppen. |
Concept
MedicationUse describes taking or administering the medication, often in relation to a prescription, but also on the person’s own initiative. This describes the pattern of medication use, as reported by the patient themselves, a caregiver or healthcare provider. Documenting medication use provides insight into the use of prescribed medication as well as the use of medication at home.
Purpose
Recording medication information is a very important part of continuity in healthcare. It concerns the core of patient safety. Healthcare professionals in the collaborative branch must always have access to an up-to-date medication overview. Applying the building block will usually involve:
- Recording the patient’s intake of self-medication or ‘drugs’.
- Recording the medication used during a patient’s stay at the hospital.
- Medication verification: recording the active medication profile.
Information Model
![MedicationUse-v1.0.1Model(EN).png](/images/e/e3/MedicationUse-v1.0.1Model%28EN%29.png)
Type | Id | Concept | Card. | Definition | DefinitionCode | Reference | |||||||
![]() |
NL-CM:9.2.1 | ![]() |
Root concept of the MedicationUse building block. This root concept contains all data elements of the MedicationUse building block. | ||||||||||
![]() |
NL-CM:9.2.2 | ![]() |
1 | The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.
In principle, this will be the prescribed product, but the product used may differ from the prescribed product. |
| ||||||||
![]() |
NL-CM:9.2.3 | ![]() |
0..* | The agreement or order for the use of medication. |
| ||||||||
![]() |
NL-CM:9.2.4 | ![]() |
0..* | When taking stock of medication use, the dosage describes the amount and the pattern of use as reported by the patient or a healthcare provider.
The used dosage is the reported dose used by the patient. The used dosage may differ in terms of the administering schedule of the prescribed dosage in the event that the patient makes different decisions on their use of the product and reports as such. |
| ||||||||
![]() |
NL-CM:9.2.5 | ![]() |
1 | The status or status code is important in indicating the use schedule.
This attribute indicates whether the prescription is actively used, temporarily interrupted, or by now discontinued. Interrupting (home) use often occurs in the event of admittance to a healthcare facility, prior to a procedure and in response to monitoring (mirroring provisions, effect measurements, etc.). When documenting this, the following interpretations are used:
|
| ||||||||
![]() |
NL-CM:9.2.6 | ![]() |
0..1 | Reason why the use of a certain medicine was discontinued. |
| ||||||||
![]() |
NL-CM:9.2.7 | ![]() |
0..1 | Reason why the use of a certain medicine was interrupted. Here, you can choose to enter text or one of the codes. |
| ||||||||
![]() |
NL-CM:9.2.8 | ![]() |
0..1 | Comments on the medication use. |
Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page
Example Instances
Only available in Dutch
GebruiksProduct | GebruiksDosering | MedicatieGebruikStatus | Voorschrift | |||
ProductNaam | StartDatum | EindDatum | Keerdosis | Toedieningsschema | ToedieningsWeg | Reden van Voorschrijven | |
Probleem | ||||||
Paracetamol tablet 500 mg | 05-2012 | Zo nodig 500mg (=1st), max. 4x/dag | Oraal | Actief | Hoofdpijn |
GebruiksProduct | GebruiksDosering | MedicatieGebruikStatus | Voorschrift | |||
ProductNaam | StartDatum | EindDatum | Keerdosis | Toedieningsschema | ToedieningsWeg | Reden van Voorschrijven | |
Probleem | ||||||
Pantoprazol injpdr 40mg fl | 11-09-2012 17:21 | 1x/dag(8u) 40mg (=1st) | iv | Actief | Ulcusprofylaxe |
GebruiksProduct | GebruiksDosering | MedicatieGebruikStatus | Voorschrift | |||
ProductNaam | StartDatum | EindDatum | Keerdosis | Toedieningsschema | ToedieningsWeg | Reden van Voorschrijven | |
Probleem | ||||||
Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml | 19-09-2012 | 1x/dag(18u) 2500ie(=0,2ml) | Subcutaan | Actief | Thrombose- profylaxe |
References
1. GROOT, E. (2011) Dataset medicatieproces 2011. [Online] Den Haag: Nictiz. Beschikbaar op: http://www.nictiz.nl/module/360/590/Dataset_Medicatieproces_2011.xlsx [Geraadpleegd: 23 juli 2014].
2. HL7v3-implementatiehandleiding medicatieproces versie 6.1.0.0. [Online] Den Haag: Nictiz. Beschikbaar op: http://www.nictiz.nl/uploaded/FILES/html_cabinet/live/Zorgtoepassing/Medicatieproces/AORTA_Mp_IH_Medicatieproces_HL7.htm [Geraadpleegd: 23 juli 2014].
3. Dossier Medicatieoverzicht. [Online] Beschikbaar op: Oria.nl. [Geraadpleegd: 23 juli 2014].
4. G-standaard documentatie. [Online] Beschikbaar op: http://www.z-index.nl/ [Geraadpleegd: 23 juli 2014].
Valuesets
MedicationUseReasonForDiscontinuationCodelist
Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.2.2 |
Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
Intolerance | SINTOL | ActReason | 2.16.840.1.113883.5.8 | Bijwerking, allergie of intolerantie |
Condition alert | COND | ActCode | 2.16.840.1.113883.5.4 | Contra-indicatie |
Drug interacts with another drug | SDDI | ActReason | 2.16.840.1.113883.5.8 | Interactie met ander medicament |
Dose change | DOSECHG | ActReason | 2.16.840.1.113883.5.8 | Dosiswijziging |
No longer required for treatment | NOREQ | ActReason | 2.16.840.1.113883.5.8 | Niet langer vereist voor de behandeling |
Ineffective | INEFFECT | ActReason | 2.16.840.1.113883.5.8 | Niet effectief |
Formulary policy | FP | ActReason | 2.16.840.1.113883.5.8 | Ander voorschrijfbeleid |
Product discontinued | DISCONT | ActReason | 2.16.840.1.113883.5.8 | Product niet meer leverbaar |
Not covered | NOTCOVER | ActReason | 2.16.840.1.113883.5.8 | Product wordt niet vergoed |
Patient refuse | PREFUS | ActReason | 2.16.840.1.113883.5.8 | Patiënt heeft geweigerd |
MedicationUseReasonForInterruptionCodelist
Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.2.3 |
Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
Drug level too high | DRUGHIGH | ActReason | 2.16.840.1.113883.5.8 | Te hoge geneesmiddel spiegel |
Lab interference issues | LABINT | ActReason | 2.16.840.1.113883.5.8 | Interferentie met gepland labonderzoek |
Patient is pregnant/breast feeding | PREG | ActReason | 2.16.840.1.113883.5.8 | Patiënt is zwangerschap of geeft borstvoeding |
Patient not-available | NON-AVAIL | ActReason | 2.16.840.1.113883.5.8 | Patiënt is niet beschikbaar |
Response to monitoring | MONIT | ActReason | 2.16.840.1.113883.5.8 | Reactie op monitoring |
Drug interacts with another drug | SDDI | ActReason | 2.16.840.1.113883.5.8 | Interactie met ander medicament |
Duplicate therapy | SDUPTHER | ActReason | 2.16.840.1.113883.5.8 | Een andere therapie maakt het gebruik tijdelijk overbodig |
Patient scheduled for surgery | SURG | ActReason | 2.16.840.1.113883.5.8 | Patient is ingepland voor een ingreep |
Waiting for old drug to wash out | WASHOUT | ActReason | 2.16.840.1.113883.5.8 | Tijdelijk onderbreken tot ander geneesmiddel geen werking meer uitoefent |
MedicationUseStatusCodelist
Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.2.1 |
Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
Active | active | ActStatus | 2.16.840.1.113883.5.14 | Actief |
Suspended | suspended | ActStatus | 2.16.840.1.113883.5.14 | Onderbroken |
Aborted | aborted | ActStatus | 2.16.840.1.113883.5.14 | Afgebroken |
Completed | completed | ActStatus | 2.16.840.1.113883.5.14 | Voltooid |
Cancelled | cancelled | ActStatus | 2.16.840.1.113883.5.14 | Niet gestart |
This information model in other releases
More on this information model
To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
- HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
- HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR
This information model is also available as pdf file or as spreadsheet
About this information
The information in this wikipage is based on Registratie aan de bron publication 2015 including errata dd. 16-07-2015
Conditions for use are located on the mainpage
This page is generated on 24/01/2018 17:12:37